Glenbeigh Explores New Treatment Protocols for Xylazine Use
When seeking treatment for xylazine use, individuals can experience intense wound pain that may be an obstacle to completing the treatment program. Patients undergoing simultaneous xylazine/opioid withdrawal may experience heightened anxiety, irritability, restlessness and hypertension.
In response, Glenbeigh began to develop symptom management protocols for withdrawal, wound care and addiction treatment as part of a quality improvement program to meet the unique and emerging needs of xylazine users. The evolving treatment plan includes the implementation of xylazine-specific testing, specialized withdrawal management, unique medication protocols, wound care and monitoring as well as psychotherapeutic treatment.
Read the entire story on xylazine protocols in the Fall 2023 Glimmer.